Search Results for "BCMA-Targeted CAR-Ts and Their Role in Late-Relapse Multiple Myeloma"

BCMA-Targeted CAR-Ts and Their Role in Late-Relapse Multiple Myeloma

Dr. Mailankody on BCMA CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma

Late Relapse Myeloma - Findings from ASH 2024

Biomarkers and patient eligibility for CAR T cell therapies in MM

CAR T-cell therapy in myeloma

PHE885 CAR-T cell therapy shows high response rates for r/r multiple myeloma in phase 1

Late-Breaking Abstract: First-in-Man Trial of CAR T Cells in Myeloma

Panel Discusses Use of Bispecifics to Treat Relapsed/Refractory Myeloma, Toxicity Considerations

Unmet needs and unanswered questions in multiple myeloma

GPRC5D and FCRH5 Targeted Therapies in Myeloma

The Latest Insights on Immune Therapies in Myeloma | 2023 IMF Patient and Family Seminar

T-Cell Engagers: targets, challenges and opportunity